Publisher
Springer Science and Business Media LLC
Reference19 articles.
1. Stuntz M, Perlaky A, des Vignes F, Kyriakides T, Glass D. The prevalence of Peyronie’s disease in the United States: a population-based study. PLoS One. 2016;11:e0150157.
2. Hartzell R. Psychosexual symptoms and treatment of Peyronie’s disease within a collaborative care model. Sex Med. 2014;2:168–77.
3. Krakhotkin DV, Chernylovskyi VA, Mottrie A, Greco F, Bugaev RA. New insights into the pathogenesis of Peyronie’s disease: a narrative review. Chronic Dis Transl Med. 2020;6:165–81.
4. Hatfield BS, King CR, Udager AM, Williamson SR, Gandhi JS, Amin MB, et al. Peyronie disease: a clinicopathologic study of 71 cases with emphasis on histopathologic patterns and prevalent metaplastic ossification. Hum Pathol. 2020;104:9–17.
5. Hoy SM. Collagenase clostridium histolyticum: a review in Peyronie’s disease. Clin Drug Investig. 2020;40:83–92.